Freenome, Inc. - Common stock (FRNM)

11.09
+0.18 (1.68%)
NASDAQ· Last Trade: Aug 7th, 10:44 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.91
Open10.90
Bid11.07
Ask11.14
Day's Range10.90 - 11.16
52 Week Range9.970 - 14.26
Volume126,588
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume785,559

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026